1 August 2013
NICE has today published its recommendations to NHS England for the Clinical Commissioning Group Outcome Indicator Set.
This framework holds Clinical Commissioning Groups accountable for both the quality of services and the health outcomes achieved through commissioning.
Duleep Allirajah, Head of Policy at Macmillan Cancer Support, says:
'We are very disappointed that recommendations for the Clinical Commissioning Group Outcome Indicator Set, which holds Clinical Commissioning Groups in England accountable for patients’ health outcomes, do not include measures on cancer patients’ experience of care, or their choice at the end of life.
'These significant gaps mean that commissioners will not be held to account for improving services for cancer patients in these fundamental areas, yet we know that having a good experience of care or receiving support to die at home, are both hugely important to cancer patients.
'It is vital that the NHS delivers the standards of care that all cancer patients should expect. We want to work with NICE and NHS England to address these gaps as soon as possible.'
Lisa Gilbert, PR and Media Officer, Macmillan Cancer Support
020 7091 2467 (out of hours 07801 307068)
Notes to Editors
About Macmillan Cancer Support
More than one in three of us will get cancer. For most of us it will be the toughest fight we ever face. And the feelings of isolation and loneliness that so many people experience make it even harder.
But you don’t have to go through it alone. The Macmillan team is with you every step of the way.
We are the nurses and therapists helping you through treatment. The experts on the end of the phone. The advisers telling you which benefits you’re entitled to. The volunteers giving you a hand with the everyday things. The campaigners improving cancer care. The community there for you online, any time. The supporters who make it all possible.
Together, we are all Macmillan Cancer Support